心脏衰竭生物标志物的基于性别的差异
Ainhoa Robles-Mezcua1,2,3,4, Nelsa González Aguado1,2,3, Antonia Pilar Martin de la Rosa1,2
1Área del Corazón, Hospital Universitario Virgen de La Victoria, Málaga, Spain.
Current heart failure reports
|May 20, 2024
概括
在心力衰竭 (HF) 生物标志物中存在性别差异. 女性表现出更高的心脏拉伸和纤维化标志物,而男性心脏损伤和炎症标志物增加,影响HF管理.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 医学中的性别差异.
背景情况:
- 荷尔蒙,遗传和脂肪分布的变化导致心力衰竭 (HF) 生物标志物水平的性别差异.
- 目前对这些与性别相关的差异及其对HF管理的临床影响的理解是有限的.
- 最近的研究证实了女性和男性之间不同的HF生物标志物概况.
研究的目的:
- 审查有关性别和各种临床情况的高频生物标志物的动态.
- 确定生物标志物中观察到的性别差异是否会影响它们在诊断和监测HF患者中的有用性.
- 探索性特定诊断标准在HF管理中的潜力.
主要方法:
- 关于HF生物标志物和性别差异的最新研究的文献综述.
- 对女性与男性的生物标志物概况的分析,包括心脏拉伸,纤维化,损伤和炎症的标志物.
- 评估支持多标志物方法和性别特定诊断模型的证据.
主要成果:
- 女性表现出更高水平的性尿素 (NP) 和加勒-3 (心脏拉伸和纤维化标志物).
- 男人表现出较高水平的心脏类素 (cTn) 和可溶性ST2 (sST2) (心脏损伤和炎症的标志物).
- 新出现的证据表明,多标志物策略可以改善高频风险分层.
结论:
- 在HF生物标志物概况中,性别特异性差异已经得到了很好的证实.
- 这些差异需要进一步研究,以完善它们在HF诊断和随访中的应用.
- 制定性别特定的诊断标准可能会增强HF管理策略.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
138
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
138
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K